跳至主要内容
临床试验/CTRI/2019/06/019814
CTRI/2019/06/019814
尚未招募
1 期

AN OPEN LABEL SINGLE ARM CLINICAL STUDY TO EVALUATE THE COMBINED EFFECT OF PIPPLAYADI TAILA MATRA BASTI AND VARUNADI KWATHA ORAL ADMINISTRATION IN THE MANAGEMENT OF POLYCYSTIC OVARIAN DISEASE

Dr Chaithra DM0 个研究点目标入组 0 人待定

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
Health Condition 1: E282- Polycystic ovarian syndrome
发起方
Dr Chaithra DM
状态
尚未招募
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
4年前
研究类型
Interventional

研究者

发起方
Dr Chaithra DM

入排标准

入选标准

  • Subjects willing to participate in study and sign the consent
  • age group of females ranging from 18 to 35 years
  • married and unmaaried females
  • subject complaining of menstrual irregularity oigomenorrhoea secondary ammenorrhoea and anovulation
  • subjects with usg findings of unilateral or bilateral polycystic ovaries
  • duration of PCOD less than 5 years

排除标准

  • subject suffering from menorrhagia adrenal hyperplasia androgen secreting neoplasm cushing syndrome
  • any organic lesion of reproductive tract like tuberculosis carcinoma and congenital deformities of any pelvic pathology uterine fibroids
  • subject with benign or malignant lesion of uterus and ovaries
  • HIV HBSAg VDRL positive subjects
  • subject diagnosed with Diabetes mellitus type 2 hypertension thyroid dysfunction

结局指标

主要结局

未指定

相似试验